Compound 1322
Identifiers
- Canonical SMILES:
Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccc(OCc3ccccc3)cc2)c1=O
- InChi:
InChI=1S/C28H20F3N5O2/c1-35-26-22(15-32-35)25-23(24(33-26)18-8-5-9-19(14-18)28(29,30)31)27(37)36(34-25)20-10-12-21(13-11-20)38-16-17-6-3-2-4-7-17/h2-15,34H,16H2,1H3
- InChiKey:
QVKDGDDQFFVYHY-UHFFFAOYSA-N
External links
![]() 168318000 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD80 / CD28 | 7.60 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 515.16 g/mol | |||
HBA | 7 | |||
HBD | 1 | |||
HBA + HBD | 8 | |||
AlogP | 6.56 | |||
TPSA | 72.28 | |||
RB | 6 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5000 | MK-0249 | DB11910 | |
0.4912 | ATX-914 | DB12673 | |
0.4701 | Tepotinib | DB15133 | |
0.4585 | 6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE | DB07218 | |
0.4494 | Riociguat | DB08931 | |
0.4416 | Decoglurant | DB11923 | |
0.4373 | Risdiplam | DB15305 | |
0.4353 | Vericiguat | DB15456 | |
0.4344 | AZD-5423 | DB12280 | |
0.4324 | Merestinib | DB12381 | |
0.4298 | MK-6186 | DB12999 | |
0.4236 | (1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid | DB07189 | |
0.4224 | Voxelotor | DB14975 | |
0.4206 | N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide | DB08349 | |
0.4184 | Ravoxertinib | DB15281 |